Research highlights the role of H3K27M in promoting oligodendrocyte precursor cell (OPC) stemness and therapeutic vulnerability in brainstem glioma organoids. This discovery could inform future treatment strategies for this aggressive brain tumor.
h3k27m drives opc stemness and intrathecal therapeutic vulnerability in brainstem glioma organoids
Original title: “H3K27M drives OPC stemness and intrathecal therapeutic vulnerability in brainstem glioma organoids.”